APA (7th ed.) Citation

You, C., Zhang, J., Lei, J., Fu, W., Liu, M., Cai, H., . . . Li, N. (2025). Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States. SAGE Publishing.

Chicago Style (17th ed.) Citation

You, Caicong, Jiahao Zhang, Jianying Lei, Wu Fu, Maobai Liu, Hongfu Cai, Bin Zheng, and Na Li. Cost-effectiveness of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer in the United States. SAGE Publishing, 2025.

MLA (9th ed.) Citation

You, Caicong, et al. Cost-effectiveness of Perioperative Durvalumab Plus Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer in the United States. SAGE Publishing, 2025.